These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29220792)

  • 21. Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria.
    Miyauchi R; Kawakami K; Ito M; Matsuhashi N; Ohki H; Inagaki H; Takahashi H; Takemura M
    Bioorg Med Chem; 2009 Oct; 17(19):6879-89. PubMed ID: 19736016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and in vitro antibacterial activity of fluoroquinolone derivatives containing a chiral 3-(alkoxyimino)-2-(aminomethyl)azetidine moiety.
    Lv K; Sun Y; Sun L; Wei Z; Guo H; Wu J; Liu M
    ChemMedChem; 2012 Jul; 7(7):1230-6. PubMed ID: 22639240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro Antibacterial Activity of 7-Substituted-6-Fluoroquinolone and 7-Substituted-6,8-Difluoroquinolone Derivatives.
    Leyva-Ramos S; de Loera D; Cardoso-Ortiz J
    Chemotherapy; 2017; 62(3):194-198. PubMed ID: 28334702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-activity relationship of amidine derivatives of 3,4-ethylenedioxythiophene as novel antibacterial agents.
    Stolić I; Čipčić Paljetak H; Perić M; Matijašić M; Stepanić V; Verbanac D; Bajić M
    Eur J Med Chem; 2015 Jan; 90():68-81. PubMed ID: 25461312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel 3-Aminothiazolquinolones: Design, Synthesis, Bioactive Evaluation, SARs, and Preliminary Antibacterial Mechanism.
    Cui SF; Addla D; Zhou CH
    J Med Chem; 2016 May; 59(10):4488-510. PubMed ID: 27115717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel cajaninstilbene acid derivatives as antibacterial agents.
    Geng ZZ; Zhang JJ; Lin J; Huang MY; An LK; Zhang HB; Sun PH; Ye WC; Chen WM
    Eur J Med Chem; 2015 Jul; 100():235-45. PubMed ID: 26093280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1923-7. PubMed ID: 11353655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of first ever 4-quinolone-3-carboxylic acid-appended spirooxindole-pyrrolidine derivatives and their biological applications.
    Arasakumar T; Mathusalini S; Ata A; Shankar R; Gopalan S; Lakshmi K; Sakthivel P; Mohan PS
    Mol Divers; 2017 Feb; 21(1):37-52. PubMed ID: 27670880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
    Plech T; Wujec M; Kosikowska U; Malm A; Rajtar B; Polz-Dacewicz M
    Eur J Med Chem; 2013 Feb; 60():128-34. PubMed ID: 23287058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformationally constrained analogs of N-substituted piperazinylquinolones: synthesis and antibacterial activity of N-(2,3-dihydro-4-hydroxyimino-4H-1-benzopyran-3-yl)-piperazinylquinolones.
    Emami S; Foroumadi A; Samadi N; Faramarzi MA; Rajabalian S
    Arch Pharm (Weinheim); 2009 Jul; 342(7):405-11. PubMed ID: 19544301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones.
    Foroumadi A; Emami S; Mehni M; Moshafi MH; Shafiee A
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4536-9. PubMed ID: 16115766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of CH
    Dai H; Hu Y; Zhang Y; Zhu Q; Xu T; Cui P; Fan R; He Q
    Eur J Med Chem; 2024 May; 271():116399. PubMed ID: 38640868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-fluorinated quinolones (NFQs): new antibacterials with unique properties against quinolone-resistant gram-positive pathogens.
    Roychoudhury S; Ledoussal B
    Curr Drug Targets Infect Disord; 2002 Mar; 2(1):51-65. PubMed ID: 12462153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antimicrobial activity of 4H-4-oxoquinolizine derivatives: consequences of structural modification at the C-8 position.
    Ma Z; Chu DT; Cooper CS; Li Q; Fung AK; Wang S; Shen LL; Flamm RK; Nilius AM; Alder JD; Meulbroek JA; Or YS
    J Med Chem; 1999 Oct; 42(20):4202-13. PubMed ID: 10514290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety.
    Zhang T; Shen W; Liu M; Zhang R; Wang M; Li L; Wang B; Guo H; Lu Y
    Eur J Med Chem; 2015 Nov; 104():73-85. PubMed ID: 26435513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel aminopiperidine derivatives for antibacterial activity against Gram-positive bacteria.
    Lee HY; An KM; Jung J; Koo JM; Kim JG; Yoon JM; Lee MJ; Jang H; Lee HS; Park S; Kang JH
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3148-3152. PubMed ID: 27173797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of membrane active benzimidazole quinolones-based topoisomerase inhibitors as potential DNA-binding antimicrobial agents.
    Zhang L; Addla D; Ponmani J; Wang A; Xie D; Wang YN; Zhang SL; Geng RX; Cai GX; Li S; Zhou CH
    Eur J Med Chem; 2016 Mar; 111():160-82. PubMed ID: 26871658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in quinolone hybrids with potential antibacterial activity against drug-resistant bacteria.
    Jun W; Yumin S; Heng Y
    Future Med Chem; 2023 Mar; 15(6):555-578. PubMed ID: 37102377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coumarin-containing hybrids and their antibacterial activities.
    Feng D; Zhang A; Yang Y; Yang P
    Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900380. PubMed ID: 32253782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA).
    Song MX; Zheng CJ; Deng XQ; Sun LP; Wu Y; Hong L; Li YJ; Liu Y; Wei ZY; Jin MJ; Piao HR
    Eur J Med Chem; 2013 Feb; 60():376-85. PubMed ID: 23314051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.